Clinical Trial: Evaluation of the Antipruritic Effect of PAC-14028 Cream in Skin Pruritus
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: A Phase II, Single Center, Double-blind, Randomized Clinical Trial to Evaluate the Efficacy and Safety of PAC-14028 Cream in Dermal Pruritus
Brief Summary: The objective of this study was to find a clinically appropriate dose of PAC-14028 cream by comparatively evaluating the efficacy and safety of PAC-14028 cream of Amorepacific Corporation in patients with dermal pruritus.
Detailed Summary:
Sponsor: Amorepacific Corporation
Current Primary Outcome: Change in Visual Analog Scale (VAS) [ Time Frame: Baseline through Study Day 28 ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
- Treatment success rate [ Time Frame: Baseline through Study Day 28 ]
- Change in specified symptom sum score (SRRC) Index [ Time Frame: Baseline through Study Day 28 ]
- Change in transepidermal water loss [ Time Frame: Baseline through Study Day 28 ]
- Change in skin hydration [ Time Frame: Baseline through Study Day 28 ]
Original Secondary Outcome: Same as current
Information By: Amorepacific Corporation
Dates:
Date Received: January 31, 2014
Date Started: January 2013
Date Completion:
Last Updated: September 11, 2015
Last Verified: September 2015